Baseline prevalence of lung cancer screening and associated factors among women in breast cancer screening clinics prior to the Pink & Pearl program: A retrospective analysis of electronic health records
Oct 2026· Research Square· 0 citations· 22 references
Medicine
TL;DR
The need for strategies to improve smoking history documentation and promote tobacco cessation efforts in cancer screening programs is highlighted and the Pink & Pearl program, a co-located breast and lung cancer screening initiative at these sites, will be evaluated.
Abstract
Abstract Introduction: Lung cancer screening (LCS) remains underutilized, with 18% uptake nationally, despite established evidence-based guidelines, particularly among women who engage with preventive care through breast cancer screening (BCS). We characterized baseline LCS uptake and its correlates among women receiving BCS at two participating hospitals. Methods We conducted a retrospective cohort study using six years of electronic health record data (October 2019–November 2025) from Barnes-Jewish West County Hospital and Christian Hospital. Women aged 50–80 with any documented smoking history were included. The primary outcome was LCS uptake, defined as evidence of at least one low-dose computed tomography scan. We conducted multivariable logistic regression models and assessed for effect modification by race and area deprivation using likelihood ratio tests. Results Of 9,686 women with smoking history, 3,209 (33.1%) had received at least one LCS. Pack-year documentation status (AOR 2.90; 95% CI: 2.63, 3.19), tobacco cessation medication use (AOR 2.21; 95% CI: 1.98, 2.48), and current smoking (AOR 1.84; 95% CI: 1.64, 2.07) were the factors most strongly associated with uptake. Non-Hispanic Black women had lower adjusted odds of obtaining LCS compared to non-Hispanic White women (AOR 0.87; 95% CI: 0.78, 0.98); estimates in the smaller pack-year subgroups were similar in direction but imprecise. Alcohol use was associated with lower odds of LCS uptake (0.81, 95% CI: 0.73, 0.89). Effect modification by race and area deprivation were not significant. Conclusions Baseline LCS uptake exceeded the national average; however, racial disparities were observed. Completeness of smoking history documentation, tobacco cessation medication use, and current smoking status were strongly associated with LCS uptake. These findings highlight the need for strategies to improve smoking history documentation and promote tobacco cessation efforts in cancer screening programs and establish the baseline against which the Pink & Pearl program, a co-located breast and lung cancer screening initiative at these sites, will be evaluated.
668
Background:
Adherence to lung cancer screening remains suboptimal. Breast cancer survivors are at increased risk for second primary malignancies, including lung cancer, underscoring the need for guideline-concordant screening during survivorship. Breast cancer survivors meeting U.S. Preventive Services Task...
Rachel Fan, M. Haireek, Milosh Djuric et al.· JCO Oncology Practice· 0 citations
Survivors were more likely to be up-to-date with CRC and cervical cancer screening but not mammography, and Absolute rates remained below national targets, suggesting increased healthcare contact alone is insufficient.
María Felix Torres-Nolasco, C. Otiniano Alvarado· JCO Oncology Practice· 0 citations
People with pre-existing mental health disorders (PMHD) often have lower cancer screening uptake and later-stage diagnoses. It remains unclear whether these disparities persist within highly accessible universal healthcare systems without strict gatekeeping. We simultaneously investigated the associations between PMHD...
Yueh-Hsin Wang, A. Aggarwal, Elizabeth A. Davies· PLoS ONE· 0 citations
The findings reveal that solely increasing the number of LCS facilities, even when accounting for the number of recommended at-risk populations, may not necessarily lead to an increase in LCS prevalence for at-risk populations.
Beomyoung Cho, S. Stallings-Smith, Hyun Kim· Cancer Control: Journal of t...· 0 citations
Background: Breast cancer is the most frequently diagnosed cancer and leading cause of cancer mortality worldwide, accounting for 2.3 million new cases and 685,000 deaths in 2020. In Cameroon, breast cancer is the leading cancer among women, representing 34.1% of new female cancer cases. Where mammography is unaffordab...
R. Amin, A. D. Touko, R. M. Tadolonkeu et al.· medRxiv· 0 citations
Introduction: Breast cancer is the most prevalent malignancy among women and a leading cause of cancer-related mortality. While mammographic screening is well established for women aged 50 years and older, its implementation for those aged 40–49 years remains controversial.
Objective: This systematic review assesses t...
Nícolas Marques Barros, Igor Diniz Alves, Walter Johnatha dos Santos Pereira et al.· Mastology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.